386 related articles for article (PubMed ID: 9766664)
21. Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1997; 39(5):431-9. PubMed ID: 9054957
[TBL] [Abstract][Full Text] [Related]
22. Hyperoxia and glutathione depletion in the isolated perfused rat liver.
Shattuck KE; Grinnell CD; Keeney SE; Noworyta K; Rassin DK
J Investig Med; 1997 Dec; 45(9):576-83. PubMed ID: 9444885
[TBL] [Abstract][Full Text] [Related]
23. Sex-dependent metabolism and biliary excretion of [2,4-14C] dinitrotoluene in isolated perfused rat livers.
Bond JA; Medinsky MA; Dent JG; Rickert DE
J Pharmacol Exp Ther; 1981 Dec; 219(3):598-603. PubMed ID: 7299687
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
Brock N; Stekar J
Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
[TBL] [Abstract][Full Text] [Related]
25. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
Imawaka H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
[TBL] [Abstract][Full Text] [Related]
26. Renal transport and disposition of Na-2-mercaptoethane sulfonate disulfide (dimesna) in the rat.
Ormstad K; Uehara N
FEBS Lett; 1982 Dec; 150(2):354-8. PubMed ID: 6819161
[TBL] [Abstract][Full Text] [Related]
27. Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
Zhao Y; Snel CA; Mulder GJ; Pang KS
Drug Metab Dispos; 1993; 21(6):1070-8. PubMed ID: 7905386
[TBL] [Abstract][Full Text] [Related]
28. Sex-specific extraction of organic anions by the rat liver.
Wang PY; Boccanfuso M; Lemay AM; Devries H; Sui J; She Y; Hill CE
Life Sci; 2008 Feb; 82(7-8):436-43. PubMed ID: 18234234
[TBL] [Abstract][Full Text] [Related]
29. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
Brock N; Pohl J
IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of flupyrazofos in the isolated perfused rat liver.
Jeong CK; Lee HY; Kim SB; Choi SJ; Kim JH; Kim K; Han SS; Lee HS
Pest Manag Sci; 2001 May; 57(5):427-31. PubMed ID: 11374159
[TBL] [Abstract][Full Text] [Related]
31. Dose and flow dependence of 5-fluorouracil elimination by the isolated perfused rat liver.
Warren BS; LaCreta FP; Kornhauser DM; Williams WM
Cancer Res; 1987 Oct; 47(20):5261-5. PubMed ID: 3652033
[TBL] [Abstract][Full Text] [Related]
32. Hepatic disposition of the acyl glucuronide1-O-gemfibrozil-beta-D-glucuronide: effects of dibromosulfophthalein on membrane transport and aglycone formation.
Sabordo L; Sallustio BC; Evans AM; Nation RL
J Pharmacol Exp Ther; 1999 Feb; 288(2):414-20. PubMed ID: 9918540
[TBL] [Abstract][Full Text] [Related]
33. Liquid chromatographic analysis of mesna and dimesna in plasma and urine of patients treated with mesna.
el-Yazigi A; Yusuf A; al-Rawithi S
Ther Drug Monit; 1995 Apr; 17(2):153-8. PubMed ID: 7624904
[TBL] [Abstract][Full Text] [Related]
34. Alteration of fexofenadine disposition in the rat isolated perfused liver following injection of bacterial lipopolysaccharide.
Tong Y; Zhang R; Ngo SN; Davey AK
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):685-9. PubMed ID: 16895540
[TBL] [Abstract][Full Text] [Related]
35. Disposition of isosteviol in the rat isolated perfused liver.
Jin H; Wang J; Gerber JP; Davey AK
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):593-7. PubMed ID: 20082626
[TBL] [Abstract][Full Text] [Related]
36. Stereoselective disposition of S-8666, a novel uricosuric antihypertensive diuretic, and its N-monodemethylated metabolite in a perfused rat liver preparation. Effect of protein binding on the kinetics of S-8666.
Higaki K; Nakano M
Drug Metab Dispos; 1992; 20(3):350-5. PubMed ID: 1355707
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna.
Cutler MJ; Urquhart BL; Velenosi TJ; Meyer Zu Schwabedissen HE; Dresser GK; Leake BF; Tirona RG; Kim RB; Freeman DJ
J Clin Pharmacol; 2012 Apr; 52(4):530-42. PubMed ID: 21505084
[TBL] [Abstract][Full Text] [Related]
38. Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: a multiple-indicator dilution study.
Geng W; Schwab AJ; Horie T; Goresky CA; Pang KS
J Pharmacol Exp Ther; 1998 Feb; 284(2):480-92. PubMed ID: 9454788
[TBL] [Abstract][Full Text] [Related]
39. Effect of flow on first-pass metabolism of drugs: single pass studies on 4-methylumbelliferone conjugation in the serially perfused rat intestine and liver preparations.
Chen J; Pang KS
J Pharmacol Exp Ther; 1997 Jan; 280(1):24-31. PubMed ID: 8996177
[TBL] [Abstract][Full Text] [Related]
40. The metabolism of d-, l- and dl-methadone in the isolated perfused rat liver.
Gerber N; Leger RM; Gordon P; Smith RG; Bauer J; Lynn RK
J Pharmacol Exp Ther; 1977 Mar; 200(3):487-95. PubMed ID: 850125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
